|Videos|November 5, 2017

Is There an Association Between Lyme Disease and Suicidality?

Robert Bransfield, MD, DLFAPA, explains the potential correlation between Lyme and associated diseases and suicidality.

Robert Bransfield, MD, DLFAPA, private practice, Psychiatry, in Red Bank, New Jersey, explains the potential correlation between Lyme and associated diseases and suicidality.

Interview Transcript (modified slightly for readability):

"If we look at the association between suicide in Lyme and associated diseases, for many years, when we would be in a room full of physicians, we would say, ‘Well, what’s the most common cause of death from Lyme disease?’ And there was a strong consensus that it was suicide. Now, some people would die from opioid overdoses that would occur, sometimes different neurological conditions or heart problems but suicide, by far, was the main cause.

When I gave a lecture recently, I asked, ‘How many of you in the audience know someone with Lyme disease who committed suicide?’ and two-thirds of the people in that room raised their hands; there were a couple of hundred people in the audience. So, it is the major cause, but it doesn’t occur immediately after someone has a bullseye rash; it’s usually several years later, and it’s a correlation, it’s been observed.

I can explain it by the physiology; just like other chronic infections, and we see it with HIV, hepatitis C, other chronic infections where there’s persistent inflammation, we can see a correlation with suicide, so it makes sense. And when we look through the medical literature, we can see that there are quite a few journal articles describing case reports. So, in looking at that, I went through a number of my old charts, and I went through 253 charts and found that a high percentage of those, 43%, had a history of being suicidal at some point.

Now, I realize that this is not representative of all patients with Lyme disease because these were the patients who went to a psychiatrist, so there were more patients who had psychiatric symptoms. But looking at other statistics, they range from 18%, some were higher—like 30%, 37%, a couple of studies, so it does seem like there is a strong correlation that occurs.

And if we try to explain it, you can explain it partly by the physiology of the biochemistry and how it affects the brain, but another explanation is that Lyme patients often feel that they have a disease that would be categorized as an invisible disability, and it’s hard for them to understand what’s happening to them. They do not get so much support from family, friends, doctors, and health care assistants, because it’s hard for people to understand it, and people look at them and they say, ‘Well, you have two arms, two legs; you seem okay. And so, there isn’t the validation, and often, there’s a frustration, and that doesn’t help. There’s a feeling of alienation in addition to the pathophysiological process. So, we do see that, and I see this frequently—people struggling with suicidal thoughts.

Another part of it is that you often see that Lyme and associated diseases are associated with a lot of psychiatric symptoms that progress years later in the course of the illness. And the additive effect of all of these symptoms can contribute to suicidality in some people. Certainly not everybody, but there is a certain population that has it, and a population that does not have that.”


Related to this article

Ebola Outbreak Tops 10,000 Cases as CDC Cites Spread to Kenya, Nigeria
The CDC reports the Bundibugyo virus outbreak in the Democratic Republic of the Congo (DRC) is now the second-largest Ebola outbreak on record. As of October 28, the agency counted 10,305 total confirmed cases and 4,996 total confirmed deaths. The overall risk to the American public and travelers remains low, and no cases tied to this outbreak have been confirmed in the US.
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.